Article

Surveillance of Myopericarditis following COVID-19 Booster Dose Vaccination in a Large Integrated Health System

2022-02-15

Abstract excerpt

<h4>Purpose</h4> The risk of myopericarditis following COVID-19 booster vaccination has not been extensively evaluated. We provide a timely case ascertainment of myocarditis following COVID-19 booster vaccine in individuals age 18-39 years from an integrated health system. <h4>Methods</h4> We studied a cohort of 65,785 Kaiser Permanente (KP) Northwest Health Plan members aged 18-39 years who received a COVID-19...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cd614dc6-1767-556b-9448-dae80fbf5777
DOI: 10.1101/2022.02.08.22270635

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Surveillance of Myopericarditis following COVID-19 Booster Dose Vaccination in a Large Integrated Health SystemDOI 10.1101/2022.02.08.22270635Read

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccinesSemantic proximity Read

Quality and methodological heterogeneity of COVID-19 vaccine safety studies focusing on the myocarditis safety signal: A systematic review, meta-analysis and meta-regressionSemantic proximity Read

Cardiac Inflammation after COVID-19 mRNA Vaccines: A Global Pharmacovigilance AnalysisSemantic proximity Read

Can sarcopenia index serve as a predictor of myocarditis from mRNA based COVID-19 vaccine, insights from clustered cases and potential involvement of micro-RNAs in its pathogenesis.Semantic proximity Read

Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workersSemantic proximity Read

COVID-19 Infection and Efficacy of Vaccination in Patients with Rheumatic Diseases During Omicron Outbreak in South Korea: A Prospective Cohort StudySemantic proximity Read

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillanceSemantic proximity Read

Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United StatesSemantic proximity Read

Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study from the RECOVER ProgramSemantic proximity Read

Adverse events of special interest for COVID-19 vaccines - background incidences vary by sex, age and time period and are affected by the pandemicSemantic proximity Read

COVID-19 Vaccine Booster Significantly Decreases the Risk of Intensive Care Unit Hospitalization in Heart Failure Patients During the Omicron Variant Wave: A Population-Based StudySemantic proximity Read

Strain Echocardiography and Cardiac MRI Evaluation of a Symptomatic Myopericarditis after the Pfizer-BioNTech mRNA COVID-19 VaccineSemantic proximity Read